Newbridge Financial Services Group’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-300
Closed -$1.04K – 1266
2025
Q3
$1.04K Hold
300
– – ﹤0.01% 1183
2025
Q2
$660 Hold
300
– – ﹤0.01% 1229
2025
Q1
$348 Hold
300
– – ﹤0.01% 983
2024
Q4
$381 Hold
300
– – ﹤0.01% 1066
2024
Q3
$1.02K Hold
300
– – ﹤0.01% 595
2024
Q2
$1.4K Sell
300
-200
-40% -$1.13K ﹤0.01% 978
2024
Q1
$3.71K Buy
500
+200
+67% +$1.66K ﹤0.01% 925
2023
Q4
$3.04K Sell
300
-3,000
-91% -$26.3K ﹤0.01% 925
2023
Q3
$25.7K Sell
3,300
-821
-20% -$7.04K 0.01% 586
2023
Q2
$33.9K Hold
4,121
– – 0.02% 553
2023
Q1
$29.9K Sell
4,121
-1,491
-27% -$13.3K 0.02% 593
2022
Q4
$49.8K Sell
5,612
-170
-3% -$1.87K 0.03% 464
2022
Q3
$71K Buy
5,782
+5,470
+1,753% +$85.2K 0.04% 365
2022
Q2
$4K Sell
312
-23
-7% -$308 ﹤0.01% 1047
2022
Q1
$6K Sell
335
-185
-36% -$3.44K ﹤0.01% 1054
2021
Q4
$14K Buy
520
+160
+44% +$5.51K 0.01% 832
2021
Q3
$15K Sell
360
-2,425
-87% -$133K 0.01% 745
2021
Q2
$158K Buy
2,785
+2,007
+258% +$74.1K 0.1% 210
2021
Q1
$33K Sell
778
-185
-19% -$10.5K 0.02% 526
2020
Q4
$68K Buy
963
+327
+51% +$13.4K 0.06% 268
2020
Q3
$18K Buy
+636
New +$20.7K 0.02% 527

Other funds holding EDIT

Newbridge Financial Services Group's EDIT Position: Q4 2025 in Review

Newbridge Financial Services Group sold out of Editas Medicine (EDIT) in Q4 2025, closing a stake of 300 shares — an estimated $1.04K sold.

Newbridge Financial Services Group first reported a position in EDIT in Q3 2020 and held it in 21 quarters. The position peaked at $158K in Q2 2021. 197 funds tracked by Wall St. Rank hold EDIT as of Q4 2025.

  • Newbridge Financial Services Group reported no remaining Editas Medicine position as of Q4 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 300 Editas Medicine shares in Q4 2025, an estimated $1.04K.
  • Newbridge Financial Services Group first reported a position in Editas Medicine in Q3 2020 and held it in 21 quarters.
  • Newbridge Financial Services Group's Editas Medicine position peaked at $158K in Q2 2021.
  • 197 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2025.

Based on Newbridge Financial Services Group's 13F filing for Q4 2025, filed 21 Jan 2026.